Stockreport

Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate [Yahoo! Finance]

Repligen Corporation  (RGEN) 
Last repligen corporation earnings: 2/20 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: repligen.com/investors
PDF Our fair value estimate is 2.3% lower than Repligen's analyst price target of US$192 Today we will run through one way of estimating the intrinsic value of Repligen C [Read more]